ライフサイエンスコーパス: gynecology

1 -based ROGY (Registration System Oncological Gynecology).

2 is increasing, especially in obstetrics and gynecology.

3 ncil on Resident Education in Obstetrics and Gynecology.

4 l prevalence of this model in obstetrics and gynecology.

5 nd lower rates in urology and obstetrics and gynecology.

6 diology and American Journal of Obstetrics & Gynecology.

7 or of the first American textbook related to gynecology.

8 the future of robotics in these two areas of gynecology.

9 ative (anesthesiology, -1.1%; obstetrics and gynecology, -0.5%; radiology, -0.4%; and neurology, -0.1

10 57 mu/RVU), maxillofacial (1.41 mu/RVU), and gynecology (1.66 mu/RVU) contributed least to hospital m

11 ommendations varied by specialty (obstetrics/gynecology, 16.4%; internal medicine, 27.5%; and family

12 s looked at general surgery, 6 at obstetrics-gynecology, 2 at urology, and 1 at otolaryngology.

13 ls (28 of 31 [90.3%]), specialized in benign gynecology (20 of 31 [64.5%]), and worked in Europe (24

14 ine, 25.33 [95% CI, 25.07-25.60], obstetrics/gynecology, 24.68 [95% CI, 24.32-25.05], pediatrics, 24.

15 subspecialties, 2 (6.9%) from obstetrics and gynecology, 3 (10.3%) family medicine, 2 (6.9%) from ane

16 nts) who practiced in general obstetrics and gynecology (39 [72%]), maternal-fetal medicine (7 [13%])

17 ine, 73.86 [95% CI, 73.33-74.39], obstetrics/gynecology, 72.36 [95% CI, 71.64-73.04], pediatrics, 73.

18 g human expertise across specialties such as gynecology and laparoscopic surgery.

19 ding to the 2009 International Federation of Gynecology and Obstetrics (FIGO) criteria (91.7%), that

20 ated with higher International Federation of Gynecology and Obstetrics (FIGO) grade (P < .0001).

21 ease, women with International Federation of Gynecology and Obstetrics (FIGO) high-risk stage I-IV ep

22 espectively; and International Federation of Gynecology and Obstetrics (FIGO) score was 0-4 in 33.3%,

23 of publication, International Federation of Gynecology and Obstetrics (FIGO) stage distribution, and

24 screening: three International Federation of Gynecology and Obstetrics (FIGO) stage I (including bord

25 irmed high-risk [International Federation of Gynecology and Obstetrics (FIGO) stage I/II of non-endom

26 s diagnosed with International Federation of Gynecology and Obstetrics (FIGO) stage IB to IV cervical

27 rine cervix, The International Federation of Gynecology and Obstetrics (FIGO) stage IB-IVA disease or

28 nsistent with an International Federation of Gynecology and Obstetrics (FIGO) stage IB3 squamous cell

29 chemotherapy in International Federation of Gynecology and Obstetrics (FIGO) stage IC-IV epithelial

30 nectomy revealed International Federation of Gynecology and Obstetrics (FIGO) stage II endometrial ca

31 biopsy-confirmed International Federation of Gynecology and Obstetrics (FIGO) stage III to IV epithel

32 e as well as the International Federation of Gynecology and Obstetrics (FIGO) stage of ECs, respectiv

33 d with advancing International Federation of Gynecology and Obstetrics (FIGO) stage.

34 cervical cancer, International Federation of Gynecology and Obstetrics (FIGO) stages IIB through IVA,

35 by the modified International Federation of Gynecology and Obstetrics (FIGO) staging system for uter

36 newly diagnosed International Federation of Gynecology and Obstetrics (FIGO; 1988) stage IC-IIA high

37 t Affairs), the Association of Professors of Gynecology and Obstetrics (to clerkship directors), and

38 December 2017 of International Federation of Gynecology and Obstetrics 2009 stage IA2 or IB1 squamous

39 y-stage disease (International Federation of Gynecology and Obstetrics [FIGO] stage I-IIa, grade 3 or

40 dvanced disease (International Federation of Gynecology and Obstetrics [FIGO] stage III), for which t

41 trioid carcinoma International Federation of Gynecology and Obstetrics grade 3, uterine serous carcin

42 surgical stage, International Federation of Gynecology and Obstetrics grade, or adjuvant treatment.

43 The International Federation of Gynecology and Obstetrics have produced standardized ter

44 with high-risk (International Federation of Gynecology and Obstetrics score >/= 7) gestational troph

45 ecologic cancer (International Federation of Gynecology and Obstetrics stage 0 to IIIB).

46 re predominantly International Federation of Gynecology and Obstetrics stage I and low grade.

47 tion therapy for International Federation of Gynecology and Obstetrics stage I or II carcinoma of the

48 ts had high-risk International Federation of Gynecology and Obstetrics stage I or stage II to IV epit

49 nical remission, International Federation of Gynecology and Obstetrics stage I-IV.

50 316 were eligible and most had Federation of Gynecology and Obstetrics stage IB(1) and squamous cell

51 3-42 years) with International Federation of Gynecology and Obstetrics stage IB1 cervical carcinoma w

52 26 patients with International Federation of Gynecology and Obstetrics stage IB2-IIb were randomly as

53 77 patients with International Federation of Gynecology and Obstetrics stage Ic to IV disease to six

54 newly diagnosed International Federation of Gynecology and Obstetrics stage IC-IIA high-grade serous

55 newly diagnosed International Federation of Gynecology and Obstetrics stage IC-IV epithelial ovarian

56 ically confirmed International Federation of Gynecology and Obstetrics stage IC-IV ovarian cancer and

57 in patients with International Federation of Gynecology and Obstetrics stage IIB to IV ovarian, fallo

58 ients with LACC (International Federation of Gynecology and Obstetrics stage IIB to IVA or with posit

59 gic diagnosis of International Federation of Gynecology and Obstetrics stage III or IV epithelial ova

60 an 75 years with International Federation of Gynecology and Obstetrics stage III or IV tumors receive

61 h advanced mEOC (International Federation of Gynecology and Obstetrics stage III or IV) who underwent

62 Patients with International Federation of Gynecology and Obstetrics stage III to IV ovarian cancer

63 60 patients with International Federation of Gynecology and Obstetrics stage IV EOC who underwent pri

64 rian cancer (any International Federation of Gynecology and Obstetrics stage) 9 or fewer months previ

65 tus, tumor size, International Federation of Gynecology and Obstetrics stage, tumor grade, pelvic nod

66 ents with higher International Federation of Gynecology and Obstetrics stage.

67 logic grade, and International Federation of Gynecology and Obstetrics stage.

68 s, stratified by International Federation of Gynecology and Obstetrics stage/residual tumor.

69 nts had clinical International Federation of Gynecology and Obstetrics stages IB2 (n = 79), IIA (n =

70 otherapy and had International Federation of Gynecology and Obstetrics stages II to IV or relapsed st

71 advanced-stage (International Federation of Gynecology and Obstetrics stages IIIC and IV) ovarian ca

72 the 2009 revised International Federation of Gynecology and Obstetrics staging of gynecologic maligna

73 role in the 2018 International Federation of Gynecology and Obstetrics staging system for uterine cer

74 OGCT include the International Federation of Gynecology and Obstetrics staging system's stage, residu

75 btypes and FIGO (International Federation of Gynecology and Obstetrics) stages of EC were included, b

76 dical Colleges, Association of Professors of Gynecology and Obstetrics, and Council on Resident Educa

77 having the highest likelihood of PDI 1 were gynecology and transplant.

78 structive surgeons in the fields of urology, gynecology and urogynecology have continually adapted ne

79 edicine, family medicine, and obstetrics and gynecology) and patient survey data were linked for phys

80 ties such as general surgery, obstetrics and gynecology, and emergency medicine has increased disprop

81 psychiatry, child psychiatry, obstetrics and gynecology, and family and general practice (all P<.001)

82 logy, cardiovascular surgery, obstetrics and gynecology, and general surgery.

83 o 395 representatives of national pediatric, gynecology, and obstetrics associations, national immuni

84 thopedic surgery, otolaryngology, obstetrics/gynecology, and ophthalmology clinics of the University

85 ne calls to the department of obstetrics and gynecology, and prenatal visits with physicians.

86 otalaryngology, dermatology, obstetrics and gynecology, and surgery).

87 panded to include antenatal care, obstetrics/gynecology, and targeted mass vaccination campaigns.

88 .05 [95% CI, 1.62-2.58]), and obstetrics and gynecology (AOR, 1.64 [95% CI, 1.24-2.15]); in contrast,

89 ogy, internal medicine, family practice, and gynecology, as well as subspecialists in many fields.

90 , nephrology, psychiatry, and obstetrics and gynecology, but also from recognized experts in publishi

91 edicine, pediatrics, surgery, obstetrics and gynecology, cancer, cardiovascular diseases, infectious

92 medicine, internal medicine, obstetrics and gynecology, cardiology, pulmonary, and oncology.

93 isk-standardized rates for medicine, surgery/gynecology, cardiorespiratory, cardiovascular, and neuro

94 The authors evaluated whether an obstetrics-gynecology clinic-based collaborative depression care in

95 cal students completing an 8-week obstetrics/gynecology clinical rotation, attendance at clinical and

96 The participants, who were patients at gynecology clinics and affiliated practices of 4 US acad

97 e in the general medical care and obstetrics-gynecology clinics of an urban public hospital in Atlant

98 le patients attending one of four obstetrics-gynecology clinics.

99 disease, family planning, and obstetrics and gynecology clinics.

100 Patients at the clinical genetics or gynecology department between the ages of 25 and 40 year

101 neurosurgery, orthopedic surgery, obstetrics/gynecology, emergency medicine, and radiology eliciting

102 ded women aged 18 years or older referred to gynecology for abnormal cervical cancer screening who re

103 germane to the substudy (ie, obstetrics and gynecology for substudies 1 and 3 and pulmonology for su

104 ns of the American College of Obstetrics and Gynecology for women treated with tamoxifen.

105 ine, pediatrics, family practice, obstetrics/gynecology, general surgery, orthopedic surgery, psychia

106 dures, especially in endoscopy, laparoscopy, gynecology, genitourinary, and orthopedics.

107 efit, the American College of Obstetrics and Gynecology has recommendations for referral to gynecolog

108 ominated specialties, such as obstetrics and gynecology, have substantial inequity in leadership role

109 In comparison with obstetrics and gynecology, IDSA guideline-concordant treatment was more

110 10 among postgraduate trainees in obstetrics-gynecology in 7 LMICs (Argentina, Brazil, Democratic Rep

111 nci surgical system, was approved for use in gynecology in April 2005, many procedures were translate

112 ogists for years; it is a new concept in the gynecology literature.

113 The number of obstetrics/gynecology male graduates decreased 31.3%, while female

114 Obstetrics and gynecology may present a different pattern than that of

115 rnal medicine first compared with obstetrics/gynecology (mean difference, 0.65; 95% CI, 0.18-1.12), p

116 born at the 1st Department of Obstetrics and Gynecology, Medical University of Warsaw, from 01 Januar

117 gical centers, fertility, and obstetrics and gynecology (n=2 each); and anesthesia, hospice care, ora

118 Many specialties such as gynecology, neurosurgery, ophthalmology, and chest disor

119 l trials guide evidence-based obstetrics and gynecology (OB-GYN) but often enroll nonrepresentative p

120 e other surgical specialties, obstetrics and gynecology (OB-GYN) has been predominantly female for th

121 eening in general practice in obstetrics and gynecology (OB/GYN) clinics.

122 ticularly those in outpatient obstetrics and gynecology (OB/GYN) settings.

123 Family planning, obstetrics/gynecology (OB/GYN), or sexually transmitted disease (ST

124 ine, family medicine, pediatrics, obstetrics/gynecology [OB/GYN] and 4 surgical specialties (orthoped

125 ining of approximately 44% of obstetrics and gynecology (OBGYN) residents in the US.

126 al and ethnic diversity among obstetrics and gynecology (OBGYN), surgical, and nonsurgical residents

127 e [IM], family medicine [FM], obstetrics and gynecology [OBGYN]) and 3 largest surgical disciplines (

128 e Annals of Surgery (Ann Surg), Obstetrics & Gynecology (Obstet Gynecol), and the Journal of Pediatri

129 among any of the variables evaluated except gynecology oncology clinic patients, who had an increase

130 of Radiology Imaging Network (ACRIN) and the Gynecology Oncology Group (GOG) (ACRIN 6671/GOG 0233) an

131 knee replacement, hepatobiliary, colorectal, gynecology oncology, bariatric, general, and urological

132 cular surgery, pediatric surgery, obstetrics/gynecology, ophthalmology, and urology (n = 186).

133 al specialties (neurosurgery, obstetrics and gynecology, ophthalmology, orthopedics, and otolaryngolo

134 ally significant higher odds of PDI 1 in the gynecology (OR: 1.69, P < 0.001) and transplant (OR: 1.4

135 clusive, because family medicine, obstetrics-gynecology, orthopedic surgery, and neurology specialist

136 n 9 surgical specialties, including general, gynecology, orthopedic, otolaryngology, plastic, thoraci

137 ltiple specialties, including obstetrics and gynecology, otolaryngology, and orthopedic surgery.

138 rategies from multiple specialties (urology, gynecology, pain medicine, gastroenterology, colorectal

139 tained in 52% of urology patients and 47% of gynecology patients because of a lack of creatinine test

140 medicine, internal medicine, obstetrics and gynecology, pediatrics, and surgery.

141 stic surgery, otolaryngology, obstetrics and gynecology, physical medicine, hematology, and general h

142 acets of ovarian cancer research and routine gynecology practice.

143 rasound convened a panel of specialists from gynecology, radiology, and pathology to arrive at a cons

144 ried out in the Department of Obstetrics and Gynecology Ramon y Cajal University Hospital and HM Mont

145 w databases were searched for obstetrics and gynecology-related keywords.

146 may become a powerful tool in obstetrics and gynecology research such as in studying cervical remodel

147 e prevalence of this model in obstetrics and gynecology residencies is unknown.

148 gynecology residents and 293 obstetrics and gynecology residency program directors in the US as of J

149 of payer-based segregation in obstetrics and gynecology residency programs in the US as reported by r

150 segregation was prevalent in obstetrics and gynecology residency programs, particularly at universit

151 urvey study included all 6060 obstetrics and gynecology residents and 293 obstetrics and gynecology r

152 ics reflected demographics of obstetrics and gynecology residents nationally in terms of racial and e

153 students who completed an 8-week obstetrics/gynecology rotation were included.

154 rative depression care adapted to obstetrics-gynecology settings had a greater impact on depression o

155 rasound, were recruited at the Department of Gynecology, Skane University Hospital, Malmo.

156 habilitation (SRQ, 1.60), and obstetrics and gynecology (SRQ, 1.47).

157 h International Federation of Obstetrics and Gynecology stage III (n = 172) or IV (n = 31) epithelial

158 Among publications, gynecology studies were significantly less likely to rep

159 Patients undergoing colorectal and gynecology surgery at Memorial Sloan Kettering Cancer Ce

160 nutes) for patients receiving colorectal and gynecology surgery, respectively.

161 s, 82% occurred on four services: obstetrics-gynecology, surgery, medicine, and emergency medicine.

162 al medicine, family practice, obstetrics and gynecology, surgery, pediatrics, and psychiatry) were ma

163 rt workgroup with expertise in primary care, gynecology, surgical oncology, medical oncology, radiati

164 ncil on Resident Education in Obstetrics and Gynecology (to program directors).

165 Obstetrics and gynecology training programs can be ranked by the matern

166 Gynecology was the subspecialty with the highest rate of

167 (vs no debt), graduates choosing obstetrics/gynecology were less likely to be board certified (AOR,

168 rovider designation (eg, gastroenterology or gynecology) were not considered PCPs.

169 ic, urology, vascular, gastrointestinal, and gynecology) with antibiotic prophylaxis between October

170 Compared to clinicians in Obstetrics/Gynecology/Women's health, those in family medicine and